Hvsen Biotech released its first-quarter performance, turning a loss into a profit of 44.497 million yuan

According to the Zhitong Finance APP, Hvsen Biotech released its first-quarter report for 2025, with operating revenue of 399 million yuan, a year-on-year increase of 92.96%. The net profit attributable to shareholders of the listed company was 44.497 million yuan. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 34.0907 million yuan. The basic earnings per share were 0.2684 yuan

According to the Zhitong Finance APP, Hvsen Biotech (300871.SZ) released its first quarter report for 2025, with operating revenue of 399 million yuan, a year-on-year increase of 92.96%. The net profit attributable to shareholders of the listed company was 44.497 million yuan. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 34.0907 million yuan. The basic earnings per share were 0.2684 yuan